AUTHORS

Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

Forget a Soft Landing, We Have Now Run Out of Runway

It's time for investors to keep it simple and keep it safe.

More Members of the Market Chorus Are Singing the Third-Quarter Blues

The volume level has been building as more companies have acknowledged the negative impact of inflation and other economic stumbling blocks.

Don't Look Now, but 2022 Is Shaping Up for an Ugly Finish

A slowing economy, a weakening job market and the likelihood of political gridlock will take their toll on stocks.

This Options Play Could Turn That Frown Upside Down

Here's a trade in the small-cap creator of a Botox-like wrinkle remover.

Here's How I'm Playing This Bout of Market Uncertainty

'Ladies and Gentlemen. Please take your seats and buckle up. We are about to hit some rough air.'

Disruptive Forces Should Provide Plenty of Shorting Opportunities

It's time to be on the lookout for overvalued stocks that are likely to be taken down significantly should the economy keep contracting.

Keep One Eye on the Fed, the Other on Europe

As we worry about rate hikes from the Fed, the lights are flickering in Europe. Here are the tough questions investors need to consider now.

Bad News Beset This Biotech, but I See a Boost Ahead

TG Therapeutics could see a win with its multiple sclerosis therapy -- and I've got a lesson for traders staying nimble.

These 2 Sporting Goods Stocks Are Too Cheap to Ignore

I'm heavily underweight any part of the economy that is dependent on the American consumer. But there are exceptions.

Consumers Show Signs of Sinking and Could Pull Down Stocks With Them

That's especially true for the stocks of retailers, including the mighty Amazon.com.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight